The Board of Directors employs the Management Team of the Bellevue Asset Management Group in Europe and America for the fundamental analysis and portfolio management of BB BIOTECH. The members of the team come from a natural science (biochemistry, molecular biology), medicine (human medicine, pharmacy) and/or business management background, the majority with many years practical experience in industry. The team also has a worldwide contact network with clinicians, scientists and patent lawyers.